InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Glickman Richard M. Insider active across 2 companies, notably enGene Holdings Inc.. Cumulatively, 4 filings have been published. Activity tracked since 24 April 2024. The latest transaction was filed on 28 May 2024 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Richard M. Glickman is a declarant and has filed 4 forms in total. In the 4 most recent filings we hold, the modal transaction nature is Levée d'options, with dates ranging from 2023-11-02 to 2025-10-15, and the indicated aggregate amounts are EUR 0 for buys and EUR 0 for sells. He is a director of ESSA Pharma Inc. and enGene Holdings Inc.